These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 26693677

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany.
    Iftner T, Neis KJ, Castanon A, Landy R, Holz B, Woll-Herrmann A, Iftner A, Staebler A, Wallwiener D, Hann von Weyhern C, Neis F, Haedicke-Jarboui J, Martus P, Brucker S, Henes M, Sasieni P.
    J Clin Microbiol; 2019 Jan; 57(1):. PubMed ID: 30355760
    [Abstract] [Full Text] [Related]

  • 3. Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.
    Iftner T, Becker S, Neis KJ, Castanon A, Iftner A, Holz B, Staebler A, Henes M, Rall K, Haedicke J, von Weyhern CH, Clad A, Brucker S, Sasieni P.
    J Clin Microbiol; 2015 Aug; 53(8):2509-16. PubMed ID: 26019212
    [Abstract] [Full Text] [Related]

  • 4. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D, Aiyer A, Dockter J, Giachetti C, Zhang F, Ginocchio CC.
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human papillomavirus messenger RNA assay for cervical cancer screening: the Shenzhen Cervical Cancer Screening Trial I.
    Wu R, Belinson SE, Du H, Na W, Qu X, Wu R, Liu Y, Wang C, Zhou Y, Zhang L, Belinson JL.
    Int J Gynecol Cancer; 2010 Nov; 20(8):1411-4. PubMed ID: 21051986
    [Abstract] [Full Text] [Related]

  • 7. HPV genotyping and E6/E7 transcript assays for cervical lesion detection in an Asian screening population-Cobas and Aptima HPV tests.
    Wong OGW, Tsun OKL, Tsui EY, Chow JNK, Ip PPC, Cheung ANY.
    J Clin Virol; 2018 Dec; 109():13-18. PubMed ID: 30368218
    [Abstract] [Full Text] [Related]

  • 8. Human papillomavirus oncogenic mRNA testing for cervical cancer screening: baseline and longitudinal results from the CLEAR study.
    Reid JL, Wright TC, Stoler MH, Cuzick J, Castle PE, Dockter J, Getman D, Giachetti C.
    Am J Clin Pathol; 2015 Sep; 144(3):473-83. PubMed ID: 26276778
    [Abstract] [Full Text] [Related]

  • 9. Aptima HPV Assay versus Hybrid Capture® 2 HPV test for primary cervical cancer screening in the HPV FOCAL trial.
    Cook DA, Smith LW, Law J, Mei W, van Niekerk DJ, Ceballos K, Gondara L, Franco EL, Coldman AJ, Ogilvie GS, Jang D, Chernesky M, Krajden M.
    J Clin Virol; 2017 Feb; 87():23-29. PubMed ID: 27988420
    [Abstract] [Full Text] [Related]

  • 10. HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    Huijsmans CJ, Geurts-Giele WR, Leeijen C, Hazenberg HL, van Beek J, de Wild C, van der Linden JC, van den Brule AJ.
    BMC Cancer; 2016 Nov 28; 16(1):922. PubMed ID: 27894291
    [Abstract] [Full Text] [Related]

  • 11. Validation of a Human Papillomavirus (HPV) DNA Cervical Screening Test That Provides Expanded HPV Typing.
    Demarco M, Carter-Pokras O, Hyun N, Castle PE, He X, Dallal CM, Chen J, Gage JC, Befano B, Fetterman B, Lorey T, Poitras N, Raine-Bennett TR, Wentzensen N, Schiffman M.
    J Clin Microbiol; 2018 May 28; 56(5):. PubMed ID: 29491018
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer.
    Ratnam S, Coutlee F, Fontaine D, Bentley J, Escott N, Ghatage P, Gadag V, Holloway G, Bartellas E, Kum N, Giede C, Lear A.
    J Clin Microbiol; 2011 Feb 28; 49(2):557-64. PubMed ID: 21147950
    [Abstract] [Full Text] [Related]

  • 15. Comparative evaluation of three commercial systems for detection of high-risk human papillomavirus in cervical and vaginal ThinPrep PreservCyt samples and correlation with biopsy results.
    Binnicker MJ, Pritt BS, Duresko BJ, Espy MJ, Grys TE, Zarka MA, Kerr SE, Henry MR.
    J Clin Microbiol; 2014 Oct 28; 52(10):3763-8. PubMed ID: 25122861
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Aptima and hybrid capture-2 HPV tests and Pap test in the referral population in Japan.
    Kuroki H, Sakamoto J, Shibata T, Takakura M, Sasagawa T.
    J Med Virol; 2021 Aug 28; 93(8):5076-5083. PubMed ID: 33634473
    [Abstract] [Full Text] [Related]

  • 17. Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.
    Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M.
    J Clin Virol; 2018 Nov 28; 108():32-37. PubMed ID: 30223252
    [Abstract] [Full Text] [Related]

  • 18. Increased HPV detection by the use of a pre-heating step on vaginal self-samples analysed by Aptima HPV assay.
    Borgfeldt C, Forslund O.
    J Virol Methods; 2019 Aug 28; 270():18-20. PubMed ID: 31002831
    [Abstract] [Full Text] [Related]

  • 19. Diagnostic Performance of HPV E6/E7 mRNA and HPV DNA Assays for the Detection and Screening of Oncogenic Human Papillomavirus Infection among Woman with Cervical Lesions in China.
    Wang HY, Lee D, Park S, Kim G, Kim S, Han L, Yubo R, Li Y, Park KH, Lee H.
    Asian Pac J Cancer Prev; 2015 Aug 28; 16(17):7633-40. PubMed ID: 26625774
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.